Early intervention with empirical antibacterials is essential in the treatment of ventilator-associated pneumonia

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.6, 2011-06, pp. : 9-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

8 vs 15 days of antibacterials for ventilator-associated pneumonia

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ventilator-associated pneumonia: an overview

By DiCocco Jennifer M Croce Martin A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1461-1467

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin in Patients with Early-Onset Ventilator-Associated Pneumonia

By Pea F.

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 589-598

Adis International

Access to resources Recommend Favorite

Early and potent antibacterial therapy is central to effective management of ventilator-associated pneumonia

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 2, 2007-02 ,pp. : 11-13

Adis International

Access to resources Recommend Favorite

Antibiotic prophylaxis strategies in the prevention of ventilator-associated pneumonia

By Sirvent Josep-Maria Torres Antoni

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1345-1354

Informa Healthcare

Access to resources Recommend Favorite